Patents by Inventor Takeshi Ario
Takeshi Ario has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7214667Abstract: The object of the present invention is to provide a composition which exerts a higher effect on recovering health from articular disorders than that attained by amino sugars and glycosaminoglycans. The present invention solves the object by providing an agent for treating articular disorders, comprising an amino sugar and trehalose as effective ingredients.Type: GrantFiled: May 25, 2005Date of Patent: May 8, 2007Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku KenyujoInventors: Shigeharu Fukuda, Takeshi Ario, Toshio Miyake
-
Publication number: 20050277617Abstract: The object of the present invention is to provide a composition which exerts a higher effect on recovering health from articular disorders than that attained by amino sugars and glycosaminoglycans. The present invention solves the object by providing an agent for treating articular disorders, comprising an amino sugar and trehalose as effective ingredients.Type: ApplicationFiled: May 25, 2005Publication date: December 15, 2005Applicant: KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJOInventors: Shigeharu Fukuda, Takeshi Ario, Toshio Miyake
-
Publication number: 20040038929Abstract: The object of the present invention is to provide a composition which exerts a higher effect on recovering health from articular disorders than that attained by amino sugars and glycosaminoglycans. The present invention solves the object by providing an agent for treating articular disorders, comprising an amino sugar and trehalose as effective ingredients.Type: ApplicationFiled: June 23, 2003Publication date: February 26, 2004Inventors: Shigeharu Fukuda, Takeshi Ario, Toshio Miyake
-
Patent number: 6537547Abstract: Disclosed are polypeptides which originate from mammal, having L-asparaginase activity. The polypeptides are easily prepared by applying recombinant DNA techniques to DNAs encoding the polypeptides and they exert satisfactory effects in the treatment and/or the prevention for diseases caused by tumor cells dependent on L-asparagine, and cause no substantial serious side effects even when administered to humans in relatively-high dose.Type: GrantFiled: June 5, 1997Date of Patent: March 25, 2003Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku KenkyujoInventors: Takeshi Ario, Madoka Taniai, Kozo Yamamoto, Masashi Kurimoto
-
Publication number: 20030021924Abstract: The object of the present invention is to provide a fireproof container which prevents the quality deterioration of articles to be stored when exposed to a relatively high temperature condition and which has a satisfactory transportability; the above object is solved by providing a fireproof container characterized in that it comprises a container portion having partially an opening part and a lid means capable of sealing the opening part to keep the inner space of the container portion in a sealed condition and optionally capable of making the inner space into an open condition, where the container portion comprises a multilayer structure of three outer-, middle- and inner-layers positioning in this order from the outside to the inside of the container portion, wherein in the multilayer structure the outer layer comprises a fire-resistant insulating material having a bulk specific gravity of not higher than 1.Type: ApplicationFiled: June 4, 2002Publication date: January 30, 2003Inventors: Kurara Sakamoto, Takeshi Ario, Toshio Miyake
-
Patent number: 6436396Abstract: Disclosed are polypeptides which originate from mammal, having L-asparaginase activity. The polypeptides are easily prepared by applying recombinant DNA techniques to DNAs encoding the polypeptides and they exert satisfactory effects in the treatment and/or the prevention for diseases caused by tumor cells dependent on L-asparagine, and cause no substantial serious side effects even when administered to humans in relatively-high dose.Type: GrantFiled: August 8, 2000Date of Patent: August 20, 2002Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku KenkyujoInventors: Takeshi Ario, Madoka Taniai, Kozo Yamamoto, Masashi Kurimoto
-
Patent number: 6368845Abstract: Disclosed are polypeptides which originate from mammal, having L-asparaginase activity. The polypeptides are easily prepared by applying recombinant DNA techniques to DNAs encoding the polypeptides and they exert satisfactory effects in the treatment and/or the prevention for diseases caused by tumor cells dependent on L-asparagine, and cause no substantial serious side effects even when administered to humans in relatively-high dose.Type: GrantFiled: August 9, 2000Date of Patent: April 9, 2002Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku KenkyujoInventors: Takeshi Ario, Madoka Taniai, Kozo Yamamoto, Masashi Kurimoto
-
Patent number: 6274367Abstract: Disclosed is a DNA coding for mammalian L-asparaginase. Transformants introduced with the DNA effectively produce desired amounts of mammalian L-asparaginase such as those from humans, guinea pigs, and mice. The DNA is also useful as a probe for screening a DNA coding for desired mammalian L-asparaginase.Type: GrantFiled: May 11, 1999Date of Patent: August 14, 2001Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku KenkyujoInventors: Takeshi Ario, Madoka Taniai, Kakuji Torigoe, Masashi Kurimoto
-
Patent number: 6224872Abstract: A composition which comprises a flavonoid and a processed product of a plant of the genus Pfaffia. The composition effectively maintains and promotes the health, treats and prevents diseases, and exerts immunoenhancement, antiallergic, psychotropic, and/or tonic activities.Type: GrantFiled: July 20, 1998Date of Patent: May 1, 2001Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku KenkyujoInventors: Takashi Shibuya, Takeshi Ario, Shigeharu Fukuda
-
Patent number: 6140101Abstract: Disclosed are polypeptides which originate from mammal, having L-asparaginase activity. The polypeptides are easily prepared by applying recombinant DNA techniques to DNAs encoding the polypeptides and they exert satisfactory effects in the treatment and/or the prevention for diseases caused by tumor cells dependent on L-asparagine, and cause no substantial serious side effects even when administered to humans in relatively-high dose.Type: GrantFiled: November 19, 1998Date of Patent: October 31, 2000Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku KenkyujoInventors: Takeshi Ario, Madoka Taniai, Kozo Yamamoto, Masashi Kurimoto
-
Patent number: 6087151Abstract: Disclosed is a DNA coding for mammalian L-asparaginase. Transformants introduced with the DNA effectively produce desired amounts of mammalian L-asparaginase such as those from humans, guinea pigs, and mice. The DNA is also useful as a probe for screening a DNA coding for desired mammalian L-asparaginase.Type: GrantFiled: January 16, 1998Date of Patent: July 11, 2000Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku KenkyujoInventors: Takeshi Ario, Madoka Taniai, Kakuji Torigoe, Masashi Kurimoto